Relay Therapeutics, Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $897.8M | $280.1M |
| FY2022 | — | $950.2M | $151.8M |
| FY2023 | — | $752.0M | $143.7M |
| FY2024 | — | $777.8M | $124.3M |
| FY2025 | — | $567.1M | $84.0M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | — | $897.8M | $280.1M |
| FY2022 | — | $950.2M | $151.8M |
| FY2023 | — | $752.0M | $143.7M |
| FY2024 | — | $777.8M | $124.3M |
| FY2025 | — | $567.1M | $84.0M |